MedTrace Logo

Advanced Glycation End Products and Dietary Intervention in Polycystic Ovary Patients

NCT05830487 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2023-04-26

No results posted yet for this study

Summary

Recently, the negative effects of advanced glycation end products on the pathophysiology of some diseases have attracted attention. This study was planned to evaluate the effect of dietary intervention and weight loss on serum advanced glycation and disease pathogenesis in patients with polycystic ovary syndrome.

Conditions

  • Polycystic Ovary Syndrome
  • Diet Habit

Interventions

BEHAVIORAL

Low AGE diet with reduced energy and fat

This group will be given a low AGE diet with reduced energy and fat,.

BEHAVIORAL

Energy and fat-reduced normal diet

This group will be given a diet with reduced energy and fat, and AGE levels will not be interfered with

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • merve özdemir · researcher

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-30
Primary Completion
2023-09-30
Completion
2023-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05830487 on ClinicalTrials.gov